Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 37 of 1,261
  1. EP 4567715

    ERZEUGUNG SYNTHETISCHER DARSTELLUNGEN

    BAYER AG [DE] · Granted Jun 11, 2025 · Expires Jun 6, 2045

    granted
  2. US 12324798

    Leonurine nanocomposite hydrogel and preparation methods and applications thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  3. US 12325703

    Fused ring compound as FGFR and VEGFR dual inhibitor

    CGeneTech (Suzhou, China) CO., Ltd. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  4. US 12324802

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  5. US 12325705

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  6. US 12324837

    ROR1-specific antigen binding molecules

    ALMAC DISCOVERY LIMITED · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  7. US 12325747

    Human PD-L1 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  8. US 12324828

    Conjugates of a factor VIII moiety having an oxime-containing linkage

    Nektar Therapeutics · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  9. US 12324787

    Kits for preparing and delivering purified corticotropin

    ANI Pharmaceuticals, Inc. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  10. US 12324812

    Glucopyranosyl derivatives and their uses

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  11. US 12324843

    Compositions and methods for delivery of biomacromolecule agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  12. US 12325710

    Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders

    The Regents of the University of California · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  13. US 12325711

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  14. US 12325715

    Fluorous metal chelates compositions

    The Regents of the University of California · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  15. US 12325733

    Binding domain

    AUTOLUS LIMITED · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  16. US 12325708

    Adenosine 2 receptor antagonists

    Nektar Therapeutics · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  17. US 12325732

    Pro-insulin aspart structure and method for preparing insulin aspart

    AMPHASTAR NANJING PHARMACEUTICALS INC · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  18. US 12325755

    Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

    The Regents of the University of California · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  19. US 12326492

    Systems and methods of detecting interstitial cystitis

    LIPELLA PHARMACEUTICALS, INC. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  20. US 12325753

    Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  21. US 12325854

    Crispr-CPF1-related methods, compositions and components for cancer immunotherapy

    Editas Medicine, Inc. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  22. US 12325752

    Immunoglobulin proteins that bind to NPR1 agonists

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  23. US 12325699

    Antibacterial compounds

    BLACKSMITH MEDICINES, INC. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  24. US 12325688

    Gingerenone A prodrugs as sensotherapeutics and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.